Physician profile
Fallon Harrington
NPI 1487048427
$1,626.95
in general payments reported to CMS, 2019-2025
11 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $342 · 2022: $387 · 2023: $361 · 2024: $366 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $711.20 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $267.74 | 2021-2024 | Farxiga |
| Abbott Laboratories | $257.77 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.29 | 2024-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $75.68 | 2023-2024 | Assure Wcd |
| Novo Nordisk INC | $44.85 | 2023-2024 | Ozempic, Rybelsus |
| Amgen INC. | $37.38 | 2023 | Repatha |
| Janssen Pharmaceuticals, INC | $34.72 | 2022-2023 | Xarelto |
| Pfizer INC. | $27.63 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.97 | 2021 | |
| Boston Scientific Corporation | $13.72 | 2024 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fallon Harrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.